Dr. Jaimin Dudhia, MD

Dr. Dudhia practices at Jersey Shore University Medical Center in Neptune, New Jersey, part of Hackensack Meridian Health.

Dr. Dudhia's NPI, 1609261544, was assigned on March 30, 2015. Dr. Dudhia holds New Jersey license D11249500.

Dr. Dudhia's primary practice is Jersey Shore University Medical Center, at 1945 Rte 33, Neptune, NJ 07754 in Monmouth County. The practice phone is (732) 775-5500.

Dr. Dudhia's primary practice is Jersey Shore University Medical Center in Neptune, New Jersey, part of Hackensack Meridian Health. Dr. Dudhia is also affiliated with JFK University Medical Center. The medical group on file is TeamHealth Hospitalists. Dmand AI also links Dr. Dudhia to 3 more medical groups, 2 group practices and clinics, 1 home health agency and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dudhia practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Dudhia's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Dudhia is licensed in New Jersey.

CMS data shows 2,057 Medicare services from Dr. Dudhia across 5 procedure codes in 2024, for 722 Medicare patients. Medicare paid $187,920 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 722 Medicare patients who saw Dr. Dudhia in 2024. The largest group is 75 to 84, with 278 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dudhia's median patient age at 77, with 51% women.

In 2024, Dr. Dudhia wrote 439 Medicare Part D claims for 199 patients. 87% of them were for generic drugs. CMS names the drug for 154 of them, across 8 drugs with 11 or more claims each, at $704 in total drug cost. In 2023, CMS named 203 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 69 out of 100 for Dr. Dudhia for performance year 2024, reported individually. Dr. Dudhia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dudhia as offering telehealth.

Dmand AI links 2 papers to Dr. Dudhia, published from 2015 to 2018. Dr. Dudhia's most frequent co-authors are Sharen G. Anghel, MD, Steven Clark Cunningham, MD and Maham Farshidpour, MD.

CMS Open Payments shows 24 general payments to Dr. Dudhia from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $267.